![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 34, 26316-26321, August 25, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Molecular Pathology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan
Received for publication, December 20, 1999, and in revised form, May 11, 2000
| |
ABSTRACT |
|---|
|
|
|---|
Members of the SNF2/SWI2 family, characterized
with sequence motifs similar to those found in DNA and RNA helicases,
play roles in various aspects of cellular fundamental processes such as
transcriptional regulation, chromosome stability, nucleotide excision
repair, and recombination. We have isolated a novel member of the human
SNF2/SWI2 family, RAD54B, which is highly homologous to
mammalian RAD54. The RAD54 gene is a member of
the RAD52 epistasis group which is involved in the
recombinational repair of DNA damage. Here we demonstrate that human
Rad54B (hRad54B), like human Rad54 (hRad54), associates with human
Rad51 (hRad51). Both hRad54B and hRad54 associate with hRad51 through
their NH2-terminal domains, but there are differences in
their ways of association with hRad51. In contrast to Rad54, whose
association with Rad51 is induced by ionizing radiation, Rad54B
associates with Rad51 constitutively in immunoprecipitation
experiments. Also, the failure to detect the interaction between
hRad54B and hRad51 in the yeast two-hybrid assay suggests that their
interaction, unlike that between hRad54 and hRad51, may be indirect.
Immunofluorescence microscopy revealed that hRad54B formed nuclear foci
that colocalized with hRad51, hRad54, and BRCA1. These findings suggest
that Rad54B may be functionally distinct from Rad54, although it may
play an active role in recombination processes in concert with other
members of the RAD52 epistasis group.
The SNF2/SWI2 family is a still expanding superfamily of
DNA-dependent ATPases. Members of this family are involved
in various functions, such as transcriptional regulation (SNF2, MOT1,
and BRM), chromosome stability (lodestar), nucleotide excision repair (ERCC6 and Rad16), and recombination (Rad54) (1). Recently, we cloned a
novel gene of the SNF2/SWI2 family, RAD54B, which shares
homology with mammalian and yeast RAD54 (2).
In Saccharomyces cerevisiae, the RAD52 epistasis
group genes are involved in the recombinational repair of DNA damage,
including DNA double-strand breaks as well as playing a role in
meiotic recombination (3), and it has been demonstrated that the
RAD52 epistasis group genes are well conserved structurally
and functionally throughout evolution (4). RAD54 is a member
of the RAD52 epistasis group. Yeast Rad54 stimulates
homologous DNA pairing by Rad51 (5), and it was shown that homozygous
RAD54 mutants in mouse and chicken are highly radiation- and
methyl methanesulfonate-sensitive and have reduced levels of homologous
recombination (6, 7).
Human RAD54B encodes a protein of 910 amino acids. The
central part, which contains the seven helicase motifs found in members of the SNF2/SWI2 family, is well conserved between hRad54 and hRad54B,
whereas the NH2-terminal region is less conserved except the first 10 amino acids (2). The expression pattern of
RAD54B coincides with those of members of the
RAD52 epistasis group, although the functions of Rad54B are
unknown. It has been shown that in mammals, as well as in yeast, the
proteins of the RAD52 epistasis group interact with each
other and form a complex to effect the recombinational repair of
double-strand breaks (8-11). Both yeast and human Rad54
(hRad54)1 are known to
interact with Rad51 (12-14). To investigate whether hRad54B is
involved in homology-directed DNA repair, we examined the association
of hRad54B and hRad51. We demonstrate that hRad54B, like hRad54,
associates with hRad51 although it associates in a manner distinct from
hRad54. Our data suggest that Rad54B constitutes a part of a complex of
recombinational repair of double-strand breaks.
Cell Culture and DNA Transfection--
COS-7 cells, mouse
embryonic stem (ES) cells, DU145 cells (human prostate cancer), and
three human breast cancer cell lines, MCF-7, MDA-MB-231, and SkBr3,
were grown in Dulbecco's modified Eagle's medium. HCT116 (human colon
carcinoma) cells were grown in McCoy's 5A medium. BALL-1 (human B cell
leukemia) and CCRF-HSB-2 (human T cell leukemia) cells were provided by
the Riken Gene Bank (Tsukuba, Japan) and grown in RPMI 1640 medium. All
cells were maintained at 37 °C in a 5% CO2 environment,
and all culture media were supplemented with penicillin/streptomycin
and 10% fetal calf serum. Plasmids were transfected using Superfect
Transfection Reagent (Qiagen) according to the manufacturer's instructions.
Plasmid Constructions--
Human RAD51,
RAD54, and RAD54B cDNA were cloned from a
human testis cDNA library (CLONTECH
Laboratories). The part of human RAD54B encoding the
NH2-terminal 751 amino acids was placed under the SR Antibodies--
A rabbit polyclonal antiserum against hRad51 was
kindly provided by Dr. T. Ogawa (National Institute for Genetics,
Shizuoka, Japan) (15). A goat polyclonal antiserum against hRad51
(Rad51(I-20)) was purchased from Santa Cruz Biotechnology. A rabbit
polyclonal antiserum against chicken Rad54 was a gift from Dr. A. Shinohara (University of Chicago). To obtain polyclonal antibodies
against Rad54B, GST-Rad54B(1-200) was expressed in Escherichia
coli JM105 cells, purified, and used to immunize a rabbit and
hamsters as described previously (16). A mouse monoclonal antibody to
human BRCA1 (Ab-1) was purchased from Oncogene Research Products.
Anti-FLAG M2 monoclonal antibody was purchased from Sigma.
Western Blotting--
Cell extracts were prepared in radioimmune
precipitation buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.05% SDS, 1% sodium deoxycholate, 1% Triton
X-100, and 1 mM phenylmethylsulfonyl fluoride). Equal
amounts were subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and electrotransferred onto polyvinylidene difluoride filters (Millipore), then reacted with rabbit Rad54B antiserum (1:200
in dilution), rabbit Rad51 antiserum (1:200 in dilution), or anti-FLAG
M2 antibody (1:400 in dilution). The blots were visualized by ECL
blotting system (Amersham Pharmacia Biotech).
Immunoprecipitation of Lysates--
COS-7 cells cultured for
40 h after transfection were harvested in 250 µl of radioimmune
precipitation buffer/100-mm-diameter culture dish. 1 mg of cell
lysates/lane was mixed with 5 µl of rabbit or goat Rad51 antiserum,
rabbit Rad54B antiserum, or anti-FLAG M2 antibody and rotated for
1 h at 4 °C. Then samples were incubated with protein
A-Sepharose (Sigma; for rabbit antibodies) or protein G PLUS-agarose
(Santa Cruz Biotechnology; for goat and mouse antibodies) for 1 h
at 4 °C, followed by washing three times with radioimmune precipitation buffer. Immunoprecipitates were subjected to SDS-PAGE and
Western blotting. ES cells, BALL-1, CCRF-HSB-2, HCT116, and DU145 cells
were harvested 6 h after irradiation with 12 Gy of In Vitro Binding Assays--
The GST, GST-Rad54(1-242), or
GST-Rad54B(1-200) protein was expressed in E. coli JM105
cells and purified as described previously (16). Approximately 5 µg
of each protein immobilized on glutathione-Sepharose 4B (Amersham
Pharmacia Biotech) was incubated with the lysates from COS-7 cells
overexpressing hRad51 in radioimmune precipitation buffer for 1 h
at 4 °C with gentle rotation. The protein-GST beads were washed five
times with radioimmune precipitation buffer and subjected to SDS-PAGE
and Western blotting.
Yeast Two-hybrid Experiments--
Interactions were analyzed in
yeast reporter strain SFY526 by measuring the levels of
Immunofluorescent Cell Staining--
DU145, MCF-7, MDA-MB-231,
and SkBr3 cells were grown on coverslips. BALL-1 and CCRF-HSB-2 cells
were centrifuged onto glass slides at 500 rpm for 5 min. The cells were
fixed in Interaction of Overexpressed hRad54B and hRad51--
First, we
investigated the association of hRad54B with hRad51 in COS-7 cells
expressing the first 751 amino acids of hRad54B (Rad54B(1-751))
together with hRad51. For this purpose, we raised a rabbit antiserum
against the GST fusion of the first 200 amino acids of hRad54B
(GST-Rad54B(1-200)). A band of the expected molecular mass was
only detected in the COS-7 cells transfected with the Rad54B(1-751)
expression vector (Fig. 1A).
After immunoprecipitation with Rad54B antiserum or rabbit Rad51
antiserum, these immunoprecipitates were analyzed by immunoblotting
using Rad54B antiserum and Rad51 antiserum. hRad51 was
coimmunoprecipitated with Rad54B(1-751), showing the association
between hRad54B and hRad51 (Fig. 1A). Rad54B(1-751) was
coimmunoprecipitated with hRad51 when hRad51 was overexpressed and even
when not overexpressed in a lower amount, probably because of the high
expression level of endogenous Rad51.
Interaction of Endogenous Rad54B and Rad51--
Next we examined
the association of endogenous Rad54B and Rad51 in various cell lines.
To investigate the role for Rad54B in the DNA damage response, we
treated the cells with IR or left them untreated. It was
reported that genotoxic stress induced the interaction between Rad51
and Rad54 without affecting the expression levels of Rad54 (18). The
Rad54B antiserum, but not preimmune serum, recognized a band of about
100 kDa corresponding to endogenous Rad54B in the extracts from ES
cells, BALL-1, CCRF-HSB-2, HCT116, and DU145 (Fig. 1B and
data not shown). This antiserum did not cross-react with Rad54, a
protein with a molecular mass of about 85 kDa (data not shown). The
expression levels of Rad54B did not change after treatment of the cells
with IR in all the cell lines examined (Fig. 1B and
data not shown). In contrast to Rad54, coimmunoprecipitated Rad54B with
Rad51 was detected in both irradiated and nonirradiated cells in all of
the cell lines examined, suggesting that the association is
constitutive (Fig. 1B and data not shown). We detected
Rad54B coimmunoprecipitated with Rad51 after long exposure of
chemiluminescence, probably because of the low expression level of
endogenous Rad54B and the weak association of Rad54B with Rad51. We
could hardly find Rad51 coimmunoprecipitated with Rad54B (data not shown).
Association with hRad51 Is Mediated by the
NH2-terminal Region of hRad54B--
Both the yeast
and human Rad54 proteins are known to interact with Rad51 through the
NH2-terminal domains (12-14). We therefore performed an
in vitro binding assay to examine the interaction of the
NH2-terminal domain of hRad54B and hRad51.
GST-Rad54B(1-200) immobilized on glutathione-Sepharose beads was
incubated with the lysates from COS-7 cells overexpressing hRad51. GST
fusion with the NH2-terminal 242 amino acids of hRad54
(GST-Rad54(1-242)) was used as a positive control. As shown in Fig.
2, the hRad51 protein bound to
GST-Rad54B(1-200) as well as GST-Rad54(1-242), indicating that
hRad54B interacts with hRad51 through the NH2 terminus of
hRad54B. The amount of GST-Rad54(1-242) used was smaller than that of
GST-Rad54B(1-200), but the amount of hRad51 bound to GST-Rad54(1-242)
was comparable to that of hRad51 bound to GST-Rad54B(1-200),
suggesting that the association between hRad54B and hRad51 may be
weaker than the association between hRad54 and hRad51.
In an effort to confirm the existence of a physical interaction between
the NH2-terminal region of hRad54B and hRad51 in
vivo, we asked whether hRad51 would form a complex with
epitope-tagged hRad54B in COS-7 cells expressing the FLAG-tagged
NH2-terminal 251 amino acids (FLAG-Rad54B(1-251)) or
COOH-terminal 659 amino acids (FLAG-Rad54B(252-910)) of hRad54B
together with hRad51. Fig. 3 shows that
hRad51 was detected in an anti-FLAG immunoprecipitate only when
expressed with FLAG-Rad54B(1-251), but not with FLAG-Rad54B(252-910). In a reciprocal experiment, goat Rad51 antiserum immunoprecipitation of
a FLAG-Rad54B(1-251)-transfected COS-7 lysate coimmunoprecipitated FLAG-Rad54B(1-251) (Fig. 3). In contrast, FLAG-Rad54B(252-910) was not coimmunoprecipitated with hRad51. Thus, further evidence of the
specific complex formation between hRad54B and hRad51 through the
NH2-terminal region of hRad54B was obtained.
Analysis of Interactions of hRad54B in the Yeast Two-hybrid
System--
To investigate the direct association of hRad54B with
hRad51, we performed the yeast two-hybrid assay. The Gal4 DNA binding domain and the activation domain were fused to hRad51, hRad54, and
hRad54B. These constructs were transformed into yeast reporter strain
SFY526, and the hRad54B Colocalizes with hRad51, hRad54, and BRCA1 in the
Nucleus--
hRad51 is known to form nuclear foci that increase by
irradiation (19). Both BRCA1 and Rad54 colocalize with Rad51 (18, 20).
We investigated the colocalization of hRad54B with these proteins. The
rabbit Rad54B antiserum was used to visualize the distribution of
hRad54B in various cell lines. We found that hRad54B is concentrated
focally in small and discrete sites throughout the nucleoplasm in all
of the cell lines examined (BALL-1, CCRF-HSB-2, DU145, MCF-7,
MDA-MB-231, and SkBr3 cells (data not shown)). Use of preimmune serum,
as well as omission of either the primary or secondary antibody,
resulted in the absence of focally concentrated nuclear
immunofluorescence (data not shown). The cells with hRad54B foci
increased after IR treatment in these cell lines (Table
II and data not shown). Two-color
confocal immunostaining with rabbit Rad54B antiserum and mouse BRCA1
monoclonal antibody revealed significant, albeit not complete,
colocalization of the hRad54B and the BRCA1 nuclear dot patterns in
DU145 cells (Fig. 4, top panels). Similar staining patterns were observed in other cell lines (data not shown). To demonstrate the colocalization of hRad54B and hRad51, we raised a hamster antiserum against GST-Rad54B(1-200) and performed two-color immunostaining with rabbit Rad51 antiserum and
hamster Rad54B antiserum. hRad51 foci detected by rabbit Rad51 antiserum showed significant colocalization with hRad54B foci detected
by hamster Rad54B antiserum (Fig. 4, middle panels). We
found the colocalization of hRad54B and hRad51 even in nonirradiated cells as well as in irradiated cells (data not shown). We also examined
the colocalization of hRad54B and hRad54 using a rabbit antiserum
against chicken Rad54. This antiserum was raised against the central,
well conserved region of chicken Rad54 and cross-reacted with hRad54
but not with hRad54B in a Western blotting (data not shown). The
immunostaining with rabbit Rad54 antiserum and hamster Rad54B antiserum
showed the substantial colocalization of hRad54 and hRad54B (Fig. 4,
bottom panels). Thus, hRad54B formed nuclear foci that
colocalized with BRCA1, hRad51, and hRad54. hRad51, hRad54, and BRCA1
nuclear foci were dramatically induced by IR, consistent with previous
findings (Table II). In contrast, we observed a slight increase in
hRad54B foci formation after IR.
RAD54B Is a Novel Member of the Mammalian RAD52 Epistasis
Group--
RAD54B was originally isolated based on its homology to the
RAD54 recombination gene (2). The expression pattern of
RAD54B coincides with those of members of the
RAD52 epistasis group. We found in this study that hRad54B
associates and colocalizes with hRad51. These findings strongly suggest
that RAD54B is a member of the mammalian RAD52
epistasis group. hRad54B associates with hRad51 through the
NH2-terminal domain of hRad54B. It is interesting that the
NH2-terminal domains of yeast and human Rad54 are also
required for the interactions with Rad51, despite the little structural
homology in the NH2-terminal domains (12-14). The
NH2-terminal sequence with the first 10 amino acids of
hRad54B nearly identical to that of hRad54 may have some roles in this association. Putative nuclear localization signals were located in the
NH2-terminal domains of both hRad54 (around amino acid position 34) and hRad54B (around amino acid position 135), implying that these domains have common functions (21).
Rad54B Associates with Rad51 in a Manner Distinct from
Rad54--
Although both Rad54 and Rad54B interact with Rad51, there
are differences between them in their ways of interacting with Rad51. First, the interaction between Rad54 and Rad51 is induced by IR, whereas that between Rad54B and Rad51 seems to be constitutive. Second,
the results of the yeast two-hybrid assay suggest that the association
of hRad54B with hRad51 may be indirect. These differences, probably
originating from the diversity in NH2-terminal regions,
imply that Rad54B has functions distinct from those of Rad54.
Biochemically, Rad54 is considered to be a protein that promotes
Rad51-mediated homologous DNA pairing through its double-stranded DNA-dependent ATPase activity (5, 22, 23). It is probable that Rad54B also has a double-stranded DNA-dependent ATPase
activity because both Rad54 and Rad54B have Walker A and B motifs
involved in ATP hydrolysis. Further study is needed to elucidate the
functional relationship between Rad54B and Rad51.
Alterations in Recombination Genes and Oncogenic
Transformation--
Several lines of evidence support the idea that
defects in homologous recombination are responsible for tumor
formation. (i) Breast tumor susceptibility gene products BRCA1 and
BRCA2 associate with Rad51 (20, 24). (ii) Nbs1, which is associated
with the Mre11-Rad50 complex, is mutated in the Nijmegen breakage
syndrome characterized by increased cancer incidence and IR sensitivity (25-27). (iii) RAD51B-HMG1C fusions are generated in
t(12;14) uterine leiomyomas (28). (iv)
BRCA1-deficient ES cells have impaired repair of DNA
double-strand breaks by homologous recombination (29). We have reported
mutations in RAD54 and RAD54B in primary tumors,
suggesting that some cancers arise through the alterations of members
of RAD52 epistasis group (2, 30). Our present finding that
Rad54B forms a complex with Rad51 strengthens the idea of a role for
recombination proteins in tumor formation.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
promoter in the vector pME18S to yield plasmid pME-Rad54B(1-751). For
tagging hRad54B fragments at the NH2 termini, the FLAG
epitope (DYKDDDDK) was inserted after the first methionine codon by
polymerase chain reaction. The fragments of the FLAG-tagged
NH2-terminal 251 amino acids and the COOH-terminal 659 amino acids of hRad54B were cloned into pME18S to yield plasmids
pME-FLAG-Rad54B(1-251) and pME-FLAG-Rad54B(252-910), respectively.
Human RAD51 cDNA was cloned into pcDNA3.1
(Invitrogen) to yield plasmid pcDNA-Rad51. A glutathione
S-transferase (GST) fusion of the NH2-terminal
200 amino acids of hRad54B (GST-Rad54B(1-200)) was constructed by ligating the fragment of the NH2-terminal 200 amino acids
of hRad54B into the pGEX-3X vector (Amersham Pharmacia Biotech).
GST-Rad54(1-242) was constructed by ligating the fragment of the
NH2-terminal 242 amino acids of hRad54 into the pGEX-1
vector (Amersham Pharmacia Biotech). For the yeast two-hybrid assay,
human RAD51, RAD54, and RAD54B
cDNA were cloned into two-hybrid vectors pGBT9 and pGAD424
(CLONTECH Laboratories) as fusion with the Gal4 DNA
binding domains and activation domains, respectively. The nucleotide
sequences corresponding to the NH2-terminal 142 amino acids
of hRad54 and the NH2-terminal 200 amino acids of hRad54B
were amplified by polymerase chain reaction and also cloned into pGBT9
and pGAD424.
-rays, and
the lysates were subjected to immunoprecipitation and Western blotting
as described above.
-galactosidase produced in a liquid assay, using
O-nitrophenyl
-D-galactopyranoside as
substrate (17). Yeast transformants were selected at 30 °C on plates
with synthetic complete medium lacking leucine and tryptophan. For the
-galactosidase assay, cells from individual colonies were grown to
saturation in the same medium. Three colonies were assayed in each case.
20 °C methanol for 30 min and then immersed in ice-cold
acetone for a few seconds to permeabilize cells for antibody staining.
After three washes with phosphate-buffered saline, the preparations
were incubated at room temperature with a 1:200 dilution of rabbit
antiserum against Rad51, Rad54, Rad54B, mouse BRCA1 monoclonal antibody (Ab-1), or hamster Rad54B antiserum for 1 h, followed by
incubation with 1:100 dilution of fluorescein isothiocyanate-conjugated
donkey anti-rabbit IgG (Chemicon International Inc.),
rhodamine-conjugated donkey anti-mouse IgG (Chemicon International
Inc.), or Texas Red-conjugated goat anti-hamster IgG (EY Laboratories
Inc.) for 1 h. For double labeling, the mixture of rabbit Rad54B
antiserum and Ab-1, Rad51 antiserum and hamster Rad54B antiserum, or
Rad54 antiserum and hamster Rad54B antiserum was used as the primary antiserum, and the appropriate combination of labeled antibodies was
used as the secondary antiserum. The cells were visualized under TCS NT
(Leica) and LSM510 (Carl Zeiss) confocal laser scanning microscopy.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (42K):
[in a new window]
Fig. 1.
Coimmunoprecipitation of hRad54B with
hRad51. A, coimmunoprecipitation of ectopic
Rad54B(1-751) with hRad51. COS-7 cells (1 × 106)
were transfected with 10 µg of the expression plasmids for
Rad54B(1-751) and hRad51 as indicated. Cells were lysed and subjected
to immunoprecipitation (IP) with Rad54B antiserum
(lanes 3 and 4) or rabbit Rad51 antiserum
(lanes 7 and 8). After SDS-PAGE, immunoblotting
for Rad54B (upper panel) or for Rad51 (lower
panel) was performed. Total cell lysates were also run on the same
gel (lanes 1, 2, 5, and 6).
Molecular mass standards (in kDa) are shown. B,
coimmunoprecipitation of endogenous Rad54B with Rad51. ES cells
(lanes 1-4) and CCRF-HSB-2 cells (lanes 5-8)
were lysed 6 h after treatment with (lanes 2,
4, 6, and 8) or without (lanes
1, 3, 5, and 7) 12 Gy of IR. The
lysates were immunoprecipitated with rabbit Rad51 antiserum and
subjected to Western blotting with Rad54B antiserum (upper
panel) or Rad51 antiserum (lower panel) (lanes
3, 4, 7, and 8). Total cell
lysates were also run on the same gel (lanes 1,
2, 5, and 6). The position of Rad54B
is marked by an arrowhead. Molecular mass standards (in kDa)
are shown.

View larger version (23K):
[in a new window]
Fig. 2.
In vitro binding of the
NH2-terminal region of hRad54B to hRad51.
A, GST-Rad54 and GST-Rad54B fusion proteins in E. coli. The figure depicts a Coomassie Blue-stained
SDS-polyacrylamide gel, showing the relative abundance of GST
(lane 1), GST-Rad54(1-242) (lane 2), and
GST-Rad54B(1-200) (lane 3) used in B. B, Rad51
antiserum recognizes a 38-kDa protein bound to GST-Rad54 and
GST-Rad54B. COS-7 cells (1 × 106) were transfected
with 10 µg of the expression plasmid for hRad51. The cells were lysed
and incubated with GST (lane 5), GST-Rad54(1-242)
(lane 6), and GST-Rad54B(1-200) (lane 7) linked
to glutathione-Sepharose beads and subjected to Western blotting with
Rad51 antiserum. The figure shows a 38-kDa band, comigrating with
hRad51 detected in total cell lysates (lane 4), specifically
associated with GST-Rad54(1-242) and GST-Rad54B(1-200). Molecular
mass standards (in kDa) are shown.

View larger version (34K):
[in a new window]
Fig. 3.
Coimmunoprecipitation of the
NH2-terminal region of hRad54B and hRad51. COS-7 cells
(1 × 106) were transfected with 10 µg of the
expression plasmid for FLAG-Rad54B(1-251) or FLAG-Rad54B(252-910) as
indicated together with the expression plasmid for hRad51. Cells were
lysed and subjected to immunoprecipitation (IP) with
anti-FLAG M2 antibody (lanes 4-6) or goat Rad51 antiserum
(Rad51(I-20)) (lanes 7-9). After SDS-PAGE, immunoblotting
for FLAG (upper panel) or for Rad51 (lower panel)
was performed. Total cell lysates were also run on the same gel
(lanes 1-3). Molecular mass standards (in kDa) are
shown.
-galactosidase activities were measured. As shown in
Table I, we confirmed the previous
finding that hRad51 associates with itself and the
NH2-terminal 142 residues of hRad54 (Rad54(1-142)) (14).
The interaction of hRad54 with hRad51 was detected only when hRad51 was
fused to the activation domain of Gal4, which was consistent with the
reported pattern. In contrast, we could not find convincing evidence
that hRad54B interacts with hRad51. In addition, we could detect
neither the interaction of hRad54B with hRad54 nor itself. These
findings suggest that hRad54B interacts with hRad51 indirectly and that
there may be other proteins mediating the complex formation.
Alternatively, the fusion of the Gal4 DNA binding domain or activation
domain to the NH2 terminus of hRad54B protein may interfere
with the binding of hRad54B to other proteins, or the interaction
between hRad54B and hRad51 is below the level of detection.
Interactions between hRad51, hRad54, and hRad54B proteins in the yeast
two-hybrid system
-Galactosidase activities (in Miller units) were measured in liquid
assay using O-nitrophenyl
-D-galactopyranoside as a substrate. The activities were
based on the average values of three colonies. Rad54(1-142) and
Rad54B(1-200) contain the first 142 amino acids of hRad54 and the
first 200 amino acids of hRad54B, respectively.
Focus formation of hRad51, hRad54, hRad54B, and BRCA1 after
-irradiation in DU145 cells
-rays, were analyzed for each experiment, and results were
summarized from three independent experiments.

View larger version (31K):
[in a new window]
Fig. 4.
Colocalization of hRad54B with BRCA1, hRad51,
and hRad54. DU145 cells were irradiated with 20 Gy and stained at
4 h after irradiation with antibodies. Top panels,
cells were stained with rabbit Rad54B antiserum followed by fluorescein
isothiocyanate-conjugated anti-rabbit antibody, and mouse BRCA1
antibody followed by rhodamine-conjugated anti-mouse antibody.
Middle panels, cells were stained with rabbit Rad51
antiserum followed by fluorescein isothiocyanate-conjugated anti-rabbit
antibody, and hamster Rad54B antiserum followed by Texas Red-conjugated
anti-hamster antibody. Bottom panels, cells were stained
with rabbit Rad54 antiserum followed by fluorescein
isothiocyanate-conjugated anti-rabbit antibody, and hamster Rad54B
antiserum followed by Texas Red-conjugated anti-hamster antibody. The
first two columns show separate stainings, and the
third column shows merged combinations.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. T. Ogawa (National Institute for Genetics, Shizuoka, Japan) for antiserum against the human Rad51 protein and Dr. A. Shinohara (University of Chicago) for the gift of antiserum against the chicken Rad54 protein. We also thank the Research Center for Molecular Medicine and Research Facilities for Laboratory Animal Sciences, Hiroshima University School of Medicine, for the use of its facilities. BALL-1 and CCRF-HSB-2 cells were provided by the Riken Gene Bank (Tsukuba, Japan). We are grateful to A. Kinomura, N. Kadomoto, and M. Kuramoto for special technical assistance and T. Nishioka for photographic work.
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 81-82-257-5828;
Fax: 81-82-256-7102; E-mail: miyag@hiroshima-u.ac.jp.
Published, JBC Papers in Press, June 14, 2000, DOI 10.1074/jbc.M910306199
| |
ABBREVIATIONS |
|---|
The abbreviations used are: hRad54, human Rad54; hRad54B, human Rad54B; hRad51, human Rad51; ES, embryonic stem; GST, glutathione S-transferase; PAGE, polyacrylamide gel electrophoresis; Gy, grays; IR, ionizing radiation.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Eisen, J. A., Sweder, K. S., and Hanawalt, P. C. (1995) Nucleic Acids Res. 23, 2715-2723 |
| 2. | Hiramoto, T., Nakanishi, T., Sumiyoshi, T., Fukuda, T., Matsuura, S., Tauchi, H., Komatsu, K., Shibasaki, Y., Inui, H., Watatani, M., Yasutomi, M., Sumii, K., Kajiyama, G., Kamada, N., Miyagawa, K., and Kamiya, K. (1999) Oncogene 18, 3422-3426 |
| 3. | Game, J. C. (1993) Semin. Cancer Biol. 4, 73-83 |
| 4. | Petrini, J. H., Bressan, D. A., and Yao, M. S. (1997) Semin. Immunol. 9, 181-188 |
| 5. | Petukhova, G., Stratton, S., and Sung, P. (1998) Nature 393, 91-94 |
| 6. | Bezzubova, O., Silbergleit, A., Yamaguchi-Iwai, Y., Takeda, S., and Buerstedde, J. M. (1997) Cell 89, 185-193 |
| 7. | Essers, J., Hendriks, R. W., Swagemakers, S. M., Troelstra, C., de Wit, J., Bootsma, D., Hoeijmakers, J. H., and Kanaar, R. (1997) Cell 89, 195-204 |
| 8. | Dosanjh, M. K., Collins, D. W., Fan, W., Lennon, G. G., Albala, J. S., Shen, Z., and Schild, D. (1998) Nucleic Acids Res. 26, 1179-1184 |
| 9. | Liu, N., Lamerdin, J. E., Tebbs, R. S., Schild, D., Tucker, J. D., Shen, M. R., Brookman, K. W., Siciliano, M. J., Walter, C. A., Fan, W., Narayana, L. S., Zhou, Z. Q., Adamson, A. W., Sorensen, K. J., Chen, D. J., Jones, N. J., and Thompson, L. H. (1998) Mol. Cell 1, 783-793 |
| 10. | Hays, S. L., Firmenich, A. A., and Berg, P. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 6925-6929 |
| 11. | Shen, Z., Cloud, K. G., Chen, D. J., and Park, M. S. (1996) J. Biol. Chem. 271, 148-152 |
| 12. | Jiang, H., Xie, Y., Houston, P., Stemke-Hale, K., Mortensen, U. H., Rothstein, R., and Kodadek, T. (1996) J. Biol. Chem. 271, 33181-33186 |
| 13. | Clever, B., Interthal, H., Schmuckli-Maurer, J., King, J., Sigrist, M., and Heyer, W. D. (1997) EMBO J. 16, 2535-2544 |
| 14. | Golub, E. I., Kovalenko, O. V., Gupta, R. C., Ward, D. C., and Radding, C. M. (1997) Nucleic Acids Res. 25, 4106-4110 |
| 15. | Terasawa, M., Shinohara, A., Hotta, Y., Ogawa, H., and Ogawa, T. (1995) Genes Dev. 9, 925-934 |
| 16. | Tanaka, K., Tanaka, T., Kurokawa, M., Imai, Y., Ogawa, S., Mitanai, K., Yazaki, Y., and Hirai, H. (1998) Blood 91, 1688-1699 |
| 17. | Guarente, L. (1983) Methods Enzymol. 101, 181-191 |
| 18. | Tan, T. L., Essers, J., Citterio, E., Swagemakers, S. M., de Wit, J., Benson, F. E., Hoeijmakers, J. H., and Kanaar, R. (1999) Curr. Biol. 9, 325-328 |
| 19. | Tashiro, S., Kotomura, N., Shinohara, A., Tanaka, K., Ueda, K., and Kamada, N. (1996) Oncogene 12, 2165-2170 |
| 20. | Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., and Livingston, D. M. (1997) Cell 88, 265-275 |
| 21. | Kanaar, R., Troelstra, C., Swagemakers, S. M., Essers, J., Smit, B., Franssen, J. H., Pastink, A., Bezzubova, O. Y., Buerstedde, J. M., Clever, B., Heyer, W. D., and Hoeijmakers, J. H. (1996) Curr. Biol. 6, 828-838 |
| 22. | Swagemakers, S. M., Essers, J., de Wit, J., Hoeijmakers, J. H., and Kanaar, R. (1998) J. Biol. Chem. 273, 28292-28297 |
| 23. | Petukhova, G., Komen, S. V., Vergano, S., Klein, H., and Sung, P. (1999) J. Biol. Chem. 274, 29453-29462 |
| 24. | Sharan, S. K., Morimatsu, M., Albrecht, U., Lim, D.-S., Regel, E., Dinh, C., Sands, A., Eichele, G., Hasty, P., and Bradley, A. (1997) Nature 386, 804-810 |
| 25. | Varon, R., Vissinga, C., Platzer, M., Cerosaletti, K. M., Chrzanowska, K. H., Saar, K., Beckmann, G., Seemanova, E., Cooper, P. R., Nowak, N. J., Stumm, M., Weemaes, C. M., Gatti, R. A., Wilson, R. K., Digweed, M., Rosenthal, A., Sperling, K., Concannon, P., and Reis, A. (1998) Cell 93, 467-476 |
| 26. | Carney, J. P., Maser, R. S., Olivares, H., Davis, E. M., Le Beau, M., Yates, J. R., III, Hays, L., Morgan, W. F., and Petrini, J. H. (1998) Cell 93, 477-486 |
| 27. | Matsuura, S., Tauchi, H., Nakamura, A., Kondo, N., Sakamoto, S., Endo, S., Smeets, D., Solder, B., Belohradsky, B. H., Der Kaloustian, V., Oshimura, M., Isomura, M., Nakamura, Y., and Komatsu, K. (1998) Nat. Genet. 19, 179-181 |
| 28. | Schoenmakers, E. F. P. M., Huysmans, C., and Van de Ven, W. J. M. (1999) Cancer Res. 59, 19-23 |
| 29. | Moynahan, M. E., Chiu, J. W., Koller, B. H., and Jasin, M. (1999) Mol. Cell 4, 511-518 |
| 30. | Matsuda, M., Miyagawa, K., Takahashi, M., Fukuda, T., Kataoka, T., Asahara, T., Inui, H., Watatani, M., Yasutomi, M., Kamada, N., Dohi, K., and Kamiya, K. (1999) Oncogene 18, 3427-3430 |
This article has been cited by other articles:
![]() |
M. Otterlei, P. Bruheim, B. Ahn, W. Bussen, P. Karmakar, K. Baynton, and V. A. Bohr Werner syndrome protein participates in a complex with RAD51, RAD54, RAD54B and ATR in response to ICL-induced replication arrest J. Cell Sci., December 15, 2006; 119(24): 5137 - 5146. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sarai, W. Kagawa, T. Kinebuchi, A. Kagawa, K. Tanaka, K. Miyagawa, S. Ikawa, T. Shibata, H. Kurumizaka, and S. Yokoyama Stimulation of Dmc1-mediated DNA strand exchange by the human Rad54B protein Nucleic Acids Res., September 11, 2006; 34(16): 4429 - 4437. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wesoly, S. Agarwal, S. Sigurdsson, W. Bussen, S. Van Komen, J. Qin, H. van Steeg, J. van Benthem, E. Wassenaar, W. M. Baarends, et al. Differential Contributions of Mammalian Rad54 Paralogs to Recombination, DNA Damage Repair, and Meiosis Mol. Cell. Biol., February 1, 2006; 26(3): 976 - 989. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Smirnova, S. Van Komen, P. Sung, and H. L. Klein Effects of Tumor-associated Mutations on Rad54 Functions J. Biol. Chem., June 4, 2004; 279(23): 24081 - 24088. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Symington Role of RAD52 Epistasis Group Genes in Homologous Recombination and Double-Strand Break Repair Microbiol. Mol. Biol. Rev., December 1, 2002; 66(4): 630 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D'Avirro, D. Truong, M. Luong, R. Kanaar, and E. Selsing Gene Conversion-Like Sequence Transfers Between Transgenic Antibody V Genes Are Independent of RAD54 J. Immunol., September 15, 2002; 169(6): 3069 - 3075. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tanaka, W. Kagawa, T. Kinebuchi, H. Kurumizaka, and K. Miyagawa Human Rad54B is a double-stranded DNA-dependent ATPase and has biochemical properties different from its structural homolog in yeast, Tid1/Rdh54 Nucleic Acids Res., March 15, 2002; 30(6): 1346 - 1353. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tsutsui, F. K. Khasanov, H. Shinagawa, H. Iwasaki, and V. I. Bashkirov Multiple Interactions Among the Components of the Recombinational DNA Repair System in Schizosaccharomyces pombe Genetics, September 1, 2001; 159(1): 91 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Vasquez, K. Marburger, Z. Intody, and J. H. Wilson Manipulating the mammalian genome by homologous recombination PNAS, July 17, 2001; 98(15): 8403 - 8410. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |